Tivdak’s Full FDA Approval: A Triumphant Victory for Metastatic Cervical Cancer Treatment
The U.S. Food and Drug Administration (FDA) has granted full approval to TIVDAK (tisotumab vedotin-tftv) for the treatment of...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Authority FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Protocol Design Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
The U.S. Food and Drug Administration (FDA) has granted full approval to TIVDAK (tisotumab vedotin-tftv) for the treatment of...
A Phase 3 trial (STRIDE-10) evaluated V116, a 21-valent pneumococcal conjugate vaccine, in adults over 50. The study compared...
In this interview, Jeffrey Sorenson, CEO of Yunu, outlines how his company is enhancing the precision and efficiency of...
Rising levels of obesity have become a global health issue, with an estimated 2.8 million people dying each year...
In the evolving field of clinical trials, Risk-Based Quality Management (RBQM) emerges as a cornerstone for enhancing trial efficiency...
Vividion Therapeutics, a biopharmaceutical company, has made a significant discovery in the development of novel cancer and immune disorder...
Exegenesis Bio, a leading genetic medicines company, unveiled encouraging clinical efficacy and safety results for their EXG001-307 gene therapy...
Incyte, a renowned biopharmaceutical company, has acquired Escient Pharmaceuticals, a pioneer in developing small molecule therapeutics for immune disorders....
The international gene therapy trial for Duchenne Muscular DystrophyDuchenne Muscular Dystrophy (DMD) using GNT0004 has unveiled promising findings at...
Medpace Holdings reported a significant financial performance for the first quarter of 2024. Revenue soared by 17.7% to $511...